# A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells

> **NCT02949414** · PHASE1 · SUSPENDED · sponsor: **Cell Therapy Catapult** · enrollment: 4 (estimated)

## Conditions studied

- Tracheomalacia
- Tracheal Stenosis

## Interventions

- **PROCEDURE:** Cadaveric decellularised tracheal scaffold seeded with autologous mesenchymal cells

## Key facts

- **NCT ID:** NCT02949414
- **Lead sponsor:** Cell Therapy Catapult
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2016-09
- **Primary completion:** 2019-09
- **Final completion:** 2024-09
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2018-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949414, "A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02949414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*